Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine

被引：0
|
作者：
Hidenobu Tanihara
Tetsuya Yamamoto
Makoto Aihara
Noriko Koizumi
Hiroomi Minami
Satoshi Kojima
Tomoyuki Isobe
Mizuho Kanazawa
Hideki Suganami
机构：
[1] Biei Municipal Hospital,Department of Ophthalmology
[2] Kaiya Eye Clinic,Prof. Kazuo Iwata Memorial Kaijin Glaucoma Center
[3] The University of Tokyo,Department of Ophthalmology
[4] Doshisha University,Department of Biomedical Engineering, Faculty of Life and Medical Sciences
[5] Kowa Company,Pharmaceutical Clinical Development Management Department
[6] Ltd.,Tokyo New Drug Research Laboratories
[7] Kowa Company,Medical Affairs Department
[8] Ltd.,Data Science Center
[9] Kowa Company,undefined
[10] Ltd.,undefined
[11] Kowa Company,undefined
[12] Ltd.,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Conjunctival hyperemia; Corneal endothelial cell; Intraocular pressure; Pupil diameter; Ripasudil–brimonidine fixed-dose combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3559 / 3573
页数：14
相关论文
共 50 条
  • [21] Fixed Combination Brimonidine-Timolol Versus Brimonidine for Treatment of Intraocular Pressure Elevation After Neodymium: YAG Laser Posterior Capsulotomy
    Oner, Veysi
    Alakus, Mehmet Fuat
    Tas, Mehmet
    Turkyilmaz, Kemal
    Iscan, Yalcin
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 576 - 580
  • [22] Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration
    Joon Mo Kim
    Ki Ho Park
    Chan Yun Kim
    Hwang Ki Kim
    Tae-Woo Kim
    Mo Sae Kim
    Japanese Journal of Ophthalmology, 2011, 55 : 356 - 361
  • [23] The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study - the FAVOR study
    Kardos, Peter
    Hagedorn-Peinz, Ina
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 69 - 77
  • [24] Effects of Brimonidine 0.2%-Timolol 0.5% Fixed-Combination Therapy for Glaucoma
    Cho, Sung Woo
    Kim, Joon Mo
    Park, Ki Ho
    Choi, Chul Young
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (05) : 407 - 413
  • [25] Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration
    Kim, Joon Mo
    Park, Ki Ho
    Kim, Chan Yun
    Kim, Hwang Ki
    Kim, Tae-Woo
    Kim, Mo Sae
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2011, 55 (04) : 356 - 361
  • [26] Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma
    Sung Woo Cho
    Joon Mo Kim
    Ki Ho Park
    Chul Young Choi
    Japanese Journal of Ophthalmology, 2010, 54 : 407 - 413
  • [27] Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study
    Katz, L. Jay
    Rauchman, Steven H.
    Cottingham, Andrew J., Jr.
    Simmons, Steven T.
    Williams, Julia M.
    Schiffman, Rhett M.
    Hollander, David A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 781 - 788
  • [28] Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy
    Motolko, Michael A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (09) : 2663 - 2667
  • [29] Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
    Fabian Lerner, S.
    Oddone, Francesco
    Lu, Da-Wen
    Sanseau, Ana
    Guarro, Merce
    Ridolfi, Antonia
    Hubatsch, Douglas
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 2411 - 2419
  • [30] Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study
    Abhyankar, Dhiraj
    Shedage, Ashish
    Gole, Milind
    Raut, Preeti
    INTERNATIONAL JOURNAL OF STD & AIDS, 2017, 28 (05) : 491 - 498
12345